Gastro-Intestinal Committee

Aims & Scope

The Gastrointestinal Committee strives to:

  • Assist in the planning of the annual meeting scientific program and the review of submitted abstracts in the field of digestive diseases
  • Review the status of CGT and regenerative medicine for digestive diseases and foster international discussion about controversies in this field
  • Publish position papers and engage scientific discourse as necessary to advance the field
  • Increase the awareness of CGT and regenerative medicine for digestive diseases, mostly in young investigators

Featured Webinar

Thirteenth TERMIS-AST-ISCT Joint Webinar featuring:

  • Dr. Sang Jin Lee - Manufacturing transplantable organs with 3D printing
  • Dr. Camillo Ricordi - Regenerative and bioengineering technologies applied to beta cell replacement

Watch the webinar

Letter from the ISCT Gastrointestinal Committee

Dr. Rachele Ciccocioppo and Dr. Giuseppe Orlando have penned a letter, on the behalf of the ISCT Gastrointestinal Committee, to further encourage the inclusion of cell and gene therapy discussions and education in the gastrointestinal field in light of recent developments. ISCT members are kindly asked to please share this letter with their colleagues in the gastrointestinal field.

View the letter.

Report of the last European Crohn’s & Colitis Organisation Congress: growing attention on organoids as disease modelling in inflammatory bowel disease.

One of the ISCT Gastrointestinal Committee's main objectives is to increase awareness of cell and gene therapies in the field of the digestive system, and to promote the safe and effective use of these medicinal therapies worldwide. To help achieve these goals, the Committee conducts regular literature reviews, selects novel research to be featured alongside critical analyses developed by Committee members, and drafts reports on important events in the field.

View the report.

ISCT Position on Diversity and Inclusiveness

International Society for Cell & Gene Therapy Releases Position Statement on Diversity and Inclusiveness. View the full statement.

ISCT, alongside ASTCT, CIBMTR, EBMT, and FACT, issue a joint statement against racism. View the joint statement.

The Committee

Co-Chair

Damián García-Olmo, MD, PhD
August 2022 - Present

Jimenez Diaz Foundation University Hospital
Madrid, Spain

Co-Chair

Vincenzo Cardinale, MD, PhD
August 2022 - Present

Sapienza University of Rome
Rome, Italy

Members

Rachele Ciccocioppo, MD
University of Verona
Verona, Italy

Gianluca Carnevale, PhD
University of Modena and Reggio Emilia

Modena, Italy

Shuji Terai, MD, PhD
Niigata University

Niigata Japan

Amish Asthana, PhD
Wake Forest Institute for Regenerative Medicine

Winston-Salem, United States


Mustapha Najimi, PhD
UCLouvain
Brussels, Belgium

Eric R. Schuur, PhD
Hepatx Corporation
Bend, United States

Giuseppe Orlando, MD, PhD
Wake Forest University

Winston-Salem, United States

Eleuterio Lombardo, PhD
Takeda Madrid, Cell Therapy Technology Center
Madrid, Spain

Basak Uygun, PhD
Harvard Medical School

Boston, United States

Hongjun Wang, PhD
Medical University of South Carolina

Charleston, United States

Adriana Migliorini, PhD
University Health Network
Toronto, Canada